Wednesday, September 20, 2017 8:34:39 PM
Insomnia , Dementia and A 2-73
Thanks for posting this new article Bourbon !
I have owned AVXL shares since 2007 and have been following closely this research since ca 2012 which clearly shows an "association " between insomnia and dementia . The two elderly family members with alzheimers for whom I am PoA and part -time caregiver both began ( 2012/2013 ) with sleep disturbances , insomnia , night wandering , etc which progressed by 2014 to full alzheimers .
I don't believe that it is known yet "which is the chicken and which is the egg " , however the fact that our A2-73 appears to work on both Alheimers and insomnia only strengthens the likelihood of a strong connection , as does the recent research which has shown that most "brain cleansing " only occurs during deep REM sleep .
Earlier this week , Dr . Rudi Tanzi, a leading Alzheimer researcher ( Harvard , Mass. General , etc ) was on the Dr. Oz Tv show and reported on some recent ALZ research presented in July at the AAIC in London , and also some of his own lab studies .
He reported that the presence of bacteria and viruses in the brain was receiving greater attention , and the formation of plaque may actually be a related defense mechanism . He said :
" We used to think that it took years for plaque to form but it turns out in studies we have done that one bacterium or one virus can trigger a plaque overnight ! "
" We have always thought that this stuff was just junk but it protects the brain against infection Plaque acts like a jail which traps the infection . Instantly this stuff accumulates around the little pathogen and intraps in infection . This is a whole shift in our thinking ! " He further noted that the accumulation of plaque will lead to alzheimers .
However , in my humble opinion , I guess one could also argue that " alzheimers/ insomnia " can lead to plaque accumulation ?!
I believe that our A 2-73 , by promoting Cellular Homeostasis ( at various stages / areas of brain function) will allow " deep sleep " and proper " brain cleansing " . I pray that it may also have a curative effect on already diseased brains !!
GTAL
Thanks for posting this new article Bourbon !
I have owned AVXL shares since 2007 and have been following closely this research since ca 2012 which clearly shows an "association " between insomnia and dementia . The two elderly family members with alzheimers for whom I am PoA and part -time caregiver both began ( 2012/2013 ) with sleep disturbances , insomnia , night wandering , etc which progressed by 2014 to full alzheimers .
I don't believe that it is known yet "which is the chicken and which is the egg " , however the fact that our A2-73 appears to work on both Alheimers and insomnia only strengthens the likelihood of a strong connection , as does the recent research which has shown that most "brain cleansing " only occurs during deep REM sleep .
Earlier this week , Dr . Rudi Tanzi, a leading Alzheimer researcher ( Harvard , Mass. General , etc ) was on the Dr. Oz Tv show and reported on some recent ALZ research presented in July at the AAIC in London , and also some of his own lab studies .
He reported that the presence of bacteria and viruses in the brain was receiving greater attention , and the formation of plaque may actually be a related defense mechanism . He said :
" We used to think that it took years for plaque to form but it turns out in studies we have done that one bacterium or one virus can trigger a plaque overnight ! "
" We have always thought that this stuff was just junk but it protects the brain against infection Plaque acts like a jail which traps the infection . Instantly this stuff accumulates around the little pathogen and intraps in infection . This is a whole shift in our thinking ! " He further noted that the accumulation of plaque will lead to alzheimers .
However , in my humble opinion , I guess one could also argue that " alzheimers/ insomnia " can lead to plaque accumulation ?!
I believe that our A 2-73 , by promoting Cellular Homeostasis ( at various stages / areas of brain function) will allow " deep sleep " and proper " brain cleansing " . I pray that it may also have a curative effect on already diseased brains !!
GTAL
Recent AVXL News
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 12/12/2025 09:05:00 PM
